CoChat

Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease: reply

Open access
de Leeuw, Karina, Bungener, Laura, Roozendaal, Caroline, Bootsma, Hendrika, Stegeman, Coen A · 2017 · Rheumatology

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Sir, We appreciated reading the letter of Piga et al. [1] in response to our recent report concerning the detection of autoantibodies directed to anti-dsDNA in SLE [2]. In this letter, they discuss their own results of serial measurements of anti-dsDNA using RIA by the Farr assay [3]. Comparable findings were obtained regarding the number of patients who had an increased anti-dsDNA >20% level in the 6 months prior to flare occurrence. Moreover, they demonstrated that intensification in immunosuppressive treatment could be effective in preventing flares in patients who experienced an increase in anti-dsDNA level ⩾50% without any symptoms (n = 64), as none of the patients who were treated (n = 15) had a flare, but 32.6% (16/49) of the non-treated patients did experienced a flare. So both our studies confirm the fact that monitoring anti-dsDNA levels is important in the follow-up of SLE patients. Their main concern is that by using enzyme-labelled anti-isotype assay (EliA), which has a high specificity but a lower sensitivity in quiescent SLE, early changes in anti-dsDNA levels are missed. However, when comparing EliA and the Farr assay, as we did in our study, the same percentages of patients with an increase of anti-dsDNA before an exacerbation were found. Also when we apply this at ⩾50% threshold instead of a ⩾20% increase, only two patients would have been missed using EliA, but also by using Farr. So, even though EliA is less sensitive in quiescent disease, an increase in anti-dsDNA levels probably will be detected by using this technique. As Piga et al. stated, a relative increase is much more important than absolute values, as steadily increased anti-dsDNA do not predict a flare. Of course, prospective studies using EliA should be performed to confirm these findings. Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript. Disclosure statement: The authors have declared no conflicts of interest.

Overview

Integrity signals

Registry

Crossref · 10.1093/rheumatology/kex314

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cited by

See all 19

Metadata

Authors
de Leeuw, K., Bungener, L., Roozendaal, C., Bootsma, H., & Stegeman, C. A.
Affiliations
University Medical Center Groningen (NL)
Venue
Rheumatology
Published
2017-08-11
Volume
56
Issue
11
Pages
2039-2040
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W2744229363
Cited by
19
References
3
Citations by year
2025: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 3 · 2018: 3
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Lara D. Veeken (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
anti-dsDNA antibodies, systemic lupus erythematosus, disease flare prediction, Farr assay, assay sensitivity and specificity, biomarkers, quiescent disease
MeSH terms
Antibodies, Antinuclear, Autoantibodies, DNA, Humans, Lupus Erythematosus, Systemic, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease: reply. https://app.cochat.ai/papers/10.1093/rheumatology/kex314
The paper
de Leeuw, K., Bungener, L., Roozendaal, C., Bootsma, H., & Stegeman, C. A. (2017). Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease: reply. Rheumatology. https://doi.org/10.1093/rheumatology/kex314

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.